» Articles » PMID: 2948147

Comparison of Plasma Atrial Natriuretic Peptide Levels in Healthy Children from Birth to Adolescence and in Children with Cardiac Diseases

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 1986 Dec 1
PMID 2948147
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

An age-related dependence of plasma ANP levels was studied in 163 healthy children (94 boys, 69 girls) between the ages of day 1 and 16 yr. In neonates during the first 2-4 days of life, significantly higher plasma ANP plasma levels (range 129-356 pg/ml, mean 227) were found compared with older infants and children (p less than 0.001). Beyond the neonatal period through adolescence no significant difference in ANP concentrations could be found between the various age groups. Plasma ANP levels ranged between 2 and 109 pg/ml (mean 47) for all age groups after the newborn period. ANP levels were also determined in 15 adult volunteers and in arterial and venous cord blood of 16 healthy newborns, and concentrations were similar to those found in children. In addition, plasma ANP levels were measured in 40 children with various cardiac diseases; 22 of 40 patients exhibited ANP levels above the upper normal range seen in control children. Of these 22 patients all except two children revealed clinical signs of heart failure. In contrast 15 of 17 children without heart failure showed plasma ANP levels within the range of control children. ANP plasma levels ranged between 93 and 967 pg/ml (mean 284) in patients with heart failure and between 15 and 118 pg/ml (mean 57) in patients without heart failure, respectively. Increased ANP levels in neonates and cardiac patients may result from increased atrial distention and reflect a compensatory mechanism to improve cardiac function by reducing pre- and afterload.

Citing Articles

Kinetics of cardiovascular and inflammatory biomarkers in paediatric dengue shock syndrome.

Chanh H, Trieu H, Tran Kim H, Huynh Ngoc Thien V, Huyen V, Moncada A Oxf Open Immunol. 2024; 5(1):iqae005.

PMID: 39193474 PMC: 11211616. DOI: 10.1093/oxfimm/iqae005.


Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure-A Comparative Review.

Gangnus T, Burckhardt B Front Pediatr. 2019; 6:420.

PMID: 30761275 PMC: 6361796. DOI: 10.3389/fped.2018.00420.


Serum Levels of Natriuretic Peptides in Children before and after Treatment for an Atrial Septal Defect, a Patent Ductus Arteriosus, and a Coarctation of the Aorta-A Prospective Study.

Eerola A, Jokinen E, Boldt T, Mattila I, Pihkala J Int J Pediatr. 2010; 2010:674575.

PMID: 20445736 PMC: 2859410. DOI: 10.1155/2010/674575.


Atrial natriuretic Peptide in young and elderly children with mild gastroenteritis.

Klar A, Haver E, Lichtstein D, Hurvitz H, Foah-Shauli T Gastroenterol Res Pract. 2009; 2009:623871.

PMID: 19587826 PMC: 2705774. DOI: 10.1155/2009/623871.


NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies.

Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L Pediatr Cardiol. 2008; 30(1):3-8.

PMID: 18600369 DOI: 10.1007/s00246-008-9258-4.